Orbit SDS
Edward Lang is Chief Business Officer at Gyroscope. Ed has almost 20 years of corporate strategy and public affairs experience in the biotechnology industry. Over the course of his career, he has supported the approval of more than 15 medicines in the fields of oncology, ophthalmology, immunology and rare disease. He has also served as a senior leader driving strategic decision-making across product portfolios, as well as the primary spokesperson for both large and small biotech companies.
This person is not in any offices
Orbit SDS
The Orbit SDS uses a flexible cannula designed to contour to the globe and access the back of the eye, targeting a subretinal location in ...